Study shows ‘bidirectional’ benefit of tofacitinib in rheumatoid arthritis patients with comorbid type 2 diabetes: Study
Italy: Treatment with tofacitinib in rheumatoid arthritis (RA) with type 2 diabetes (T2D) may simultaneously improve inflammatory disease activity and insulin resistance (IR), inducing a “bidirectional” benefit in these patients, a recent study has shown. The findings were published online in Arthritis Research & Therapy on January 4, 2024. Previous studies have shown a connection […]